161 related articles for article (PubMed ID: 34532054)
61. [Pseudomyxoma peritonei (PMP) secondary to mucinous carcinoma of the ovary: a case study].
Belhamidi MS; Zorkani Y; Krimou H; Kaoukabi A; Menfaa M; Sakit F; Choho K
Pan Afr Med J; 2019; 33():283. PubMed ID: 31692896
[TBL] [Abstract][Full Text] [Related]
62. Pseudomyxoma Peritonei Arising From Urachal Mucinous Adenocarcinoma.
Dimopoulos P; Kampantais S; Payne S; Liyanage S
Urology; 2018 Jan; 111():e3-e4. PubMed ID: 29024737
[TBL] [Abstract][Full Text] [Related]
63. [Establishment of patient derived xenograft model of high-grade mucinous carcinoma peritonei accompanied with signet ring cells and identification of biological characteristics].
Lin YL; Zhang J; Yang ZR; Li XB; Ji ZH; Xu HB; Yan FC; Zhou Q; Peng Z; Li Y
Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):923-931. PubMed ID: 31874550
[No Abstract] [Full Text] [Related]
64. The relationship between diverticula and low-grade mucinous neoplasm of the appendix. Does the diverticulum play a role in the development of periappendicular mucin deposition or pseudomyxoma peritonei?
Pasaoglu E; Leblebici C; Okcu O; Boyaci C; Dursun N; Hande Yardimci A; Kucukyilmaz M
Pol J Pathol; 2016; 67(4):376-383. PubMed ID: 28547966
[TBL] [Abstract][Full Text] [Related]
65. Pseudomyxoma peritonei originating from colorectal cancer during pregnancy.
Koyama S; Tomimatsu T; Sawada K; Kanagawa T; Tsutsui T; Kimura T
J Obstet Gynaecol Res; 2011 Mar; 37(3):254-8. PubMed ID: 21114581
[TBL] [Abstract][Full Text] [Related]
66. Mucinous cystadenocarcinoma of the appendix. The controversy persists: a review.
Lo NS; Sarr MG
Hepatogastroenterology; 2003; 50(50):432-7. PubMed ID: 12749241
[TBL] [Abstract][Full Text] [Related]
67. New insights in the pathology of peritoneal surface malignancy.
Carr NJ
J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S216-S229. PubMed ID: 33968439
[TBL] [Abstract][Full Text] [Related]
68. Appendiceal goblet cell carcinoid and mucinous neoplasms are closely associated tumors: lessons from their coexistence in primary tumors and concurrence in peritoneal dissemination.
Ng D; Falck V; McConnell YJ; Mack LA; Temple WJ; Gui X
J Surg Oncol; 2014 May; 109(6):548-55. PubMed ID: 24374723
[TBL] [Abstract][Full Text] [Related]
69. Pseudomyxoma peritonei with high serum CA19-9: report of three cases.
Kuo CM; Kuo CH; Changchien CS; Chiu KW; Hsu TT
Changgeng Yi Xue Za Zhi; 1999 Mar; 22(1):94-9. PubMed ID: 10418216
[TBL] [Abstract][Full Text] [Related]
70. COX-2 expression in pseudomyxoma peritonei.
Gatalica Z; Loggie B
Cancer Lett; 2006 Nov; 244(1):86-90. PubMed ID: 16427185
[TBL] [Abstract][Full Text] [Related]
71. A case of dermatomyositis associated with pseudomyxoma peritonei originating from mucinous adenocarcinoma of the appendix.
Maekawa Y; Nakamura K; Nogami R
J Dermatol; 1992 Jul; 19(7):420-3. PubMed ID: 1328337
[TBL] [Abstract][Full Text] [Related]
72. Endometrial involvement in pseudomyxoma peritonei secondary to low-grade appendiceal mucinous neoplasm: report of 2 cases.
McVeigh G; Shah V; Longacre TA; McCluggage WG
Int J Gynecol Pathol; 2015 May; 34(3):232-8. PubMed ID: 25760906
[TBL] [Abstract][Full Text] [Related]
73. [Mucinous adenocarcinoma of the urachus and peritoneal pseudomyxoma].
Soto Delgado M; Pedrero Márquez G; Varo Solís C; Rodríguez-Rubio Cortadellas FO; Sánchez Bernal C; González Moreno D
Actas Urol Esp; 2006 Feb; 30(2):222-6. PubMed ID: 16700214
[TBL] [Abstract][Full Text] [Related]
74. [Pseudomyxoma peritonei (gelatinous peritonitis )].
Angelescu N; Bordea A; Popa E; Constantinescu N; Zodieru I; Mircea N
Chirurgia (Bucur); 2001; 96(5):443-51. PubMed ID: 12731187
[TBL] [Abstract][Full Text] [Related]
75. Peritoneal pseudomyxoma associated with synchronic malignant mucinous neoplasias of the cecum, appendix and rectum. Case report and review of the literature.
Saad-Hossne R; Prado RG; Bakonyi Neto A; Marchezan MA
Acta Cir Bras; 2007; 22(5):407-11. PubMed ID: 17923963
[TBL] [Abstract][Full Text] [Related]
76. Imaging findings of urachal mucinous cystadenocarcinoma associated with pseudomyxoma peritonei.
Takeuchi M; Matsuzaki K; Yoshida S; Nishitani H; Uehara H
Acta Radiol; 2004 May; 45(3):348-50. PubMed ID: 15239434
[TBL] [Abstract][Full Text] [Related]
77. Pseudomyxoma Peritonei as a First Manifestation of KRAS-Mutated Urachal Mucinous Cystadenocarcinoma of the Bladder: A Case Report.
Shelekhova KV; Zhuravlev AS; Krylova DD; Konstantinov AS; Shtan LV; Kheinshtein VA
Int J Surg Pathol; 2017 Sep; 25(6):563-566. PubMed ID: 28449606
[TBL] [Abstract][Full Text] [Related]
78. Prognostic significance of single isolated cells with decreased E-cadherin expression in pseudomyxoma peritonei.
Koh YW; Jun SY; Kim KR
Pathol Int; 2014 Apr; 64(4):164-72. PubMed ID: 24750186
[TBL] [Abstract][Full Text] [Related]
79. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases.
Nonaka D; Kusamura S; Baratti D; Casali P; Younan R; Deraco M
Histopathology; 2006 Oct; 49(4):381-7. PubMed ID: 16978201
[TBL] [Abstract][Full Text] [Related]
80. CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
Kozman MA; Fisher OM; Rebolledo BJ; Valle SJ; Alzahrani N; Liauw W; Morris DL
Eur J Surg Oncol; 2017 Dec; 43(12):2299-2307. PubMed ID: 28993033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
